Datavant to acquire Aetion.

Datavant, a health data platform company, agreed to acquire Aetion, real-world evidence healthcare platform. Financial terms were not disclosed. "The addition of Aetion’s team of scientists and technologists further bolsters our complementary capabilities and expertise so we can better leverage data from our ecosystem of partners to support efforts before, during, and after commercialization - generating evidence from trial to treatment and beyond to deliver life-improving therapies,” Kyle Armbrester, Datavant CEO.